Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 2.240
+0.010 (0.45%)
Sep 4, 2025, 3:42 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €161.29 million as of September 4, 2025. Its market cap has increased by 8.55% in one year.
Market Cap
161.29M
Enterprise Value
187.81M
Revenue
54.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.24
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 161.29M, an increase of 60.33%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 161.29M | 37.51% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | 1.04B | 55.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.30B |
| Sanofi | 103.28B |
| Sartorius Stedim Biotech | 17.31B |
| bioMérieux | 13.90B |
| Eurofins Scientific SE | 11.55B |
| Ipsen | 9.63B |
| ABIVAX Société Anonyme | 5.09B |
| Virbac | 2.79B |